Mechanism of miR-148b inhibiting cell proliferation and migration of Schwann cells by regulating CALR
Source abstract
Abstract
The aim of this study is to investigate the effect of miR-148b on cell proliferation and migration of Schwann cells and explore its mechanism. The miR-148b group, miR-con group and the anti-miR-148b group, anti-miR-con group, si-con group, si-CALR group, Ctrl group, CALR group were transfected into Schwann cells by liposome method; the expression of miR-148b was detected by qRT-PCR; the cell viability was detected by MTT assay; the migration of cells was detected by Transwell method; WB assay was used to detect the protein expression of CALR. Firstly, we found that compared with miR-con group and si-con group, the proliferation and migration of miR-148b group and si-CALR group were significantly down-regulated (P < .05). Moreover, compared with anti-miR-con group and Ctrl group, anti-miR-148b group and CALR group cells proliferation and migration were significantly up-regulated (P < .05). In addition, miR-148b was targeted to CALR, and silencing CALR could reverse the inhibitory effect of miR-148b on Schwann cell proliferation and migration. In conclusion, miR-148b can regulate the proliferation and migration of Schwann cells. The mechanism may be related to the targeted negative regulation of CALR, which will provide a basis for targeted therapy of peripheral nerve injury.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nerve injury and regeneration · MicroRNA in disease regulation · Circular RNAs in diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Orthopaedics, Second Military Medical University’s Jinan Clinical Medicine College
Department of Orthaopedics, General Hospital of Jinan Military Command
Department of Orthopaedics, Kuishan Section of Rizhao People’s Hospital
Guangxi International Zhuang Medicine hospital
References (20)
Show source-provided references
1. 10.1249/JSR.000000000000018610.1249/JSR.0000000000000186 ↗
2. 10.1101/gad.45570810.1101/gad.455708 ↗
3. 10.1038/nature0690410.1038/nature06904 ↗
4. 10.1007/978-1-4939-6524-3_110.1007/978-1-4939-6524-3_1 ↗
5. 10.1242/jcs.09899610.1242/jcs.098996 ↗
6. 10.1242/jcs.13167210.1242/jcs.131672 ↗
7. 10.1016/j.jprot.2016.05.01510.1016/j.jprot.2016.05.015 ↗
8. 10.1016/j.neuroscience.2017.07.01110.1016/j.neuroscience.2017.07.011 ↗
9. 10.1523/JNEUROSCI.3854-15.201610.1523/JNEUROSCI.3854-15.2016 ↗
10. 10.1177/107385841039238210.1177/1073858410392382 ↗
11. 10.1016/j.conb.2010.04.00210.1016/j.conb.2010.04.002 ↗
12. 10.1186/1471-2164-14-8410.1186/1471-2164-14-84 ↗
13. 10.1016/j.bbrc.2015.10.09710.1016/j.bbrc.2015.10.097 ↗
14. 10.1242/dmm.00106510.1242/dmm.001065 ↗
15. 10.1371/journal.pone.002461210.1371/journal.pone.0024612 ↗
16. 10.4103/1673-5374.18450410.4103/1673-5374.184504 ↗
17. Luo W, Yu Z. Calreticulin (CALR) mutation in myeloproliferative neoplasms (MPNs). Stem Cell Investig. 2015;2:16.
18. 10.1073/pnas.151013211210.1073/pnas.1510132112 ↗
19. 10.1007/s12031-011-9683-310.1007/s12031-011-9683-3 ↗
20. 10.12659/MSM.90095610.12659/MSM.900956 ↗